IP Library › Granted Patent US 12,447,048
Granted Patent B2
US 12,447,048 · App. 17/518,211 · Granted Oct 21, 2025

Systems and methods for ocular laser surgery and therapeutic treatments

Inventor: AnnMarie Hipsley (Silver Lake, OH)
Assignee: ACE VISION GROUP, INC.
A61F9/00802A61F2009/00846A61F2009/00851A61F2009/00865A61F2009/00882A61F2009/00895A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,447,048
App. No.
17/518,211
Granted
Oct 21, 2025
Kind
B2
Abstract

Disclosed are systems, devices and methods for laser microporation for rejuvenation of tissue of the eye, for example, regarding aging of connective tissue and rejuvenation of connective tissue by scleral rejuvenation. The systems, devices and methods disclosed herein restore physiological functions of the eye including restoring physiological accommodation or physiological pseudo-accommodation through natural physiological and biomechanical phenomena associated with natural accommodation of the eye. In some embodiments, the laser system may be configured to treat ocular tissue off axis or in a region of the eye which is distinct from the visual axis or directed away from the pupil of the eye where the gaze of the eye is.

Claims (24)

1. A system for delivering microporation medical treatments to biological tissue to improve biomechanics of an eye, the system comprising:

a controller;

a laser head system comprising:

a housing, a laser subsystem for generating a beam of laser radiation on a treatment-axis not aligned with a patient's visual-axis, operable for use in subsurface ablative medical treatments to create a pattern of pores that improves biomechanics, and a lens operable to focus the beam of laser irradiation onto a target tissue;

an eye tracking subsystem for tracking landmarks and movements of the eye;

a depth control subsystem for controlling a depth of microporation on the target tissue; and

wherein the controller is operable to control the movements of the laser subsystem including at least one of a pitch movement, a swivel movement and a yaw movement.

2. The system of claim 1 , further comprises a scanning system communicatively coupled to the eye tracking subsystem and the depth control subsystem for scanning a focus spot over an area of the target tissue.

3. The system of claim 1 , further comprises an avoidance subsystem for identifying biological structures or locations of the eye.

4. The system of claim 1 , further comprises one or more diffractive beam splitters.

5. The system of claim 1 , wherein the pattern of pores includes pores of a same size, shape and depth.

6. The system of claim 1 , wherein the pattern of pores includes pores of different sizes, shapes and depths.

7. The system of claim 1 , wherein the pattern of pores includes pores having equal distance.

8. The system of claim 1 , wherein the pattern of pores includes pores having different distances and wherein the pattern of the pores is at least tightly packed or tessellated or spaced.

9. The system of claim 1 , wherein a depth of the pores is proportional to a total laser energy.

10. The system of claim 1 , wherein a depth of the pores is measured and judged by the depth control subsystem.

11. The system of claim 10 , wherein the depth of the pores is measured between pulses.

12. The system of claim 10 , wherein the depth of the pores is measured and judged between pulses.

13. The system of claim 1 , wherein the pattern of pores is a spiral pattern.

14. The system of claim 13 , wherein the pattern of pores is a spiral pattern of an Archimedean spiral, a Euler spiral, a Fermat's spiral, a hyperbolic spiral, a lituus, a logarithmic spiral, a Fibonacci spiral, a golden spiral, or combinations thereof.

15. The system of claim 1 , wherein the pattern of pores is a matrix array.

16. The system of claim 1 , wherein the laser head system further comprises a display to provide eye fixation.

17. The system of claim 1 , wherein the laser head system further comprises illumination sources.

18. The system of claim 1 , wherein the laser head system further comprises a camera system to optimize eye tracking performance.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: PANTEC BIOSOLUTIONS AG; HIPSLEY, ANNMARIE
To: ACE VISION GROUP, INC.
Reel/Frame 058010/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: HAGEN, CLEMENS; HEINRICH, ARNE; MESSNER, MANUEL
To: PANTEC BIOSOLUTIONS AG
Reel/Frame 058015/0570 →
Continuity (3)
Continuation PCTUS2020031392 · May 5, 2020
Provisional Application 62843403 · May 4, 2019
Related Publication 20220125639A1 · Apr 28, 2022
References Cited (42)
US 4473074A · Vassiliadis · 1984 [cited by examiner]
US 4812613A · Gorisch · 1989 [cited by examiner]
US 4911160A · Thyzel · 1990 [cited by examiner]
US 6322216B1 · Yee · 2001 [cited by examiner]
US 6488676B1 · Glockler · 2002 [cited by examiner]
US 7871404B2 · Hipsley · 2011 [cited by applicant]
US 8348932B2 · Hipsley · 2013 [cited by applicant]
US 9510802B2 · Barthe · 2016 [cited by examiner]
US 10914942B2 · Dresser · 2021 [cited by examiner]
US 20020082466A1 · Han · 2002 [cited by examiner]
US 20050107773A1 · Bergt · 2005 [cited by examiner]
US 20080033410A1 · Rastegar · 2008 [cited by examiner]
US 20080058779A1 · Hipsley et al. · 2008 [cited by applicant]
US 20080208104A1 · Bragagna · 2008 [cited by examiner]
US 20090161827A1 · Gertner · 2009 [cited by examiner]
US 20090299262A1 · Bragagna et al. · 2009 [cited by applicant]
US 20100016843A1 · Bragagna · 2010 [cited by examiner]
US 20100312231A1 · Singh · 2010 [cited by examiner]
US 20110190798A1 · Hipsley · 2011 [cited by applicant]
US 20130093870A1 · Shibutani · 2013 [cited by applicant]
US 20140046308A1 · Bischoff · 2014 [cited by examiner]
US 20140107634A1 · Vogler · 2014 [cited by examiner]
US 20140163597A1 · Hipsley · 2014 [cited by examiner]
US 20140316388A1 · Hipsley · 2014 [cited by examiner]
US 20150157406A1 · Hipsley · 2015 [cited by applicant]
US 20150157505A1 · Neev · 2015 [cited by examiner]
US 20160183961A1 · Hipsley · 2016 [cited by applicant]
US 20170087014A1 · Potter, Jr. · 2017 [cited by examiner]
US 20170119466A1 · Hirvonen · 2017 [cited by examiner]
US 20170231697A1 · Hipsley · 2017 [cited by applicant]
US 20180000339A1 · Hipsley · 2018 [cited by applicant]
US 20180052972A1 · Hipsley et al. · 2018 [cited by applicant]
US 20180207029A1 · Herekar · 2018 [cited by examiner]
US 20190105200A1 · Hipsley · 2019 [cited by examiner]
US 20190262177A1 · Hipsley · 2019 [cited by applicant]
US 20190380795A1 · Tsao · 2019 [cited by examiner]
US 20200121389A1 · Hipsley · 2020 [cited by applicant]
US 20200185106A1 · Hipsley et al. · 2020 [cited by applicant]
US 20200391051A1 · Daly · 2020 [cited by examiner]
US 20220031503A1 · Dorin · 2022 [cited by examiner]
WO WO2018183987A1 · 2018 [cited by examiner]
PCT/US2020/031392, ISR and Written Opinion, Aug. 4, 2020. [cited by applicant]